Allogeneic CAR T Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Experience from the ALPHA2/ALPHA Clinical Studies.

Frederick L Locke, Javier L Munoz, Michael T Tees, Lazaros J Lekakis,Sven de Vos,Rajneesh Nath,Don A Stevens, Shahbaz A Malik, Geoffrey P Shouse, Mehdi Hamadani, Olalekan O Oluwole, Miguel-Angel Perales, David B Miklos, Paul W Fisher, Amy Feng,Lynn Navale, John B Le Gall, Sattva S Neelapu

Journal of clinical oncology official journal of the American Society of Clinical Oncology（2025）

引用 0|浏览0

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要